Results 91 to 100 of about 65,952 (158)

Management of postoperative nausea and vomiting: focus on palonosetron

open access: yes, 2008
Neil A Muchatuta1, Michael J Paech21Department of Anaesthesia and Pain Medicine, King Edward Memorial Hospital for Women, Perth, Western Australia; 2Pharmacology and Anaesthesiology Unit, The School of Medicine and Pharmacology, The University of Western
Michael J Paech, Neil A Muchatuta
core  

Nausea and vomiting

open access: yesPlastic and Reconstructive Surgery, 1984
openaire   +2 more sources

Preventing nausea and vomiting in women undergoing regional anesthesia for cesarean section: challenges and solutions

open access: yes, 2017
Yvonne Jelting,1 Christian Klein,1 Thomas Harlander,1 Leopold Eberhart,2 Norbert Roewer,1 Peter Kranke1 1Department of Anesthesia and Critical Care, University Hospitals of Wuerzburg, Wuerzburg, 2Department of Anesthesiology and Critical Care Medicine ...
Roewer N   +5 more
core  

Optimal management of nausea and vomiting of pregnancy

open access: yes, 2010
Neda Ebrahimi1,2, Caroline Maltepe2, Adrienne Einarson21Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada; 2Motherisk Program, The Hospital for Sick Children, Toronto, Ontario, CanadaAbstract: Nausea and vomiting of pregnancy (NVP)
Adrienne Einarson   +2 more
core  

Nausea and vomiting

open access: yesJournal of the Royal College of Physicians of Edinburgh, 2014
openaire   +2 more sources

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy

open access: yes, 2009
Rudolph M NavariIndiana University School of Medicine South Bend, South Bend, IN USAAbstract: Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life.
Rudolph M Navari
core  

Comparison of Recovery Time of Anesthesia And Complication After The Use Of Alfentanil And Remifentanil In Cataract Surgery Of Elderly [PDF]

open access: yes
Background & Objective: With consideration the daily increased development of outpatient surgeries and high rate of these operations in elderly patients, rapid and safe recovery of patients for coming back to daily life is necessary.
اخوان اکبری, قدرت   +2 more
core  

Nausea-free days up to day 10.

open access: yes
BackgroundHalofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent in vitro activity against SARS-CoV-2 virus. The safety and efficacy of halofuginone in Covid-19 patients has not been studied.MethodsWe conducted a phase II ...
Ana Tarina Alvarez Lopes (18017346)   +29 more
core   +1 more source

Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron

open access: yes, 2015
Michelle Zhou, Marko Popovic, Mark Pasetka, Natalie Pulenzas, Soha Ahrari, Edward Chow, Carlo DeAngelis Department of Pharmacy, Odette Cancer Center, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada Purpose: Nausea and
Zhou M   +6 more
core  

Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination

open access: yes, 2016
Piotr K JanickiDepartment of Anesthesiology and Perioperative Medicine, Milton S Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, PA, USAPurpose: The purpose of this review is to summarize and discuss the recently ...
Janicki PK
core  

Home - About - Disclaimer - Privacy